THE ARISING · Longevity & Healthspan
Psilocybin Reshaped Brain Connections in Mice, Separately From Hallucination-Like Behavior
Long-term stress may leave a physical mark on the brain: fewer working connections between nerve cells. A new study in mice asks whether psilocybin, the compound in "magic mushrooms," can reshape those connections, and which part of its action does the work.

This is laboratory evidence in mice, not a trial in people. The study, by Baker and colleagues, appeared in Nature Neuroscience in 2026.
Psilocybin promotes the formation and maturation of synapses, the junctions where nerve cells pass signals. It also speeds the removal of synapses that were already there. In other words, the drug appears to remodel circuits rather than simply add to them.
The authors then looked at serotonin 2A receptors, the docking sites on cells that psilocybin acts on. They focused on layer 5 pyramidal neurons, a type of cell in the brain's outer layer. Signaling through this receptor in those cells was necessary and sufficient for the synaptic remodeling, the study says. It was dispensable for the head-twitch response, a rodent stand-in for hallucination.
That separation matters. If the rewiring and the hallucination-like effect run through different routes, it may be possible in principle to study one without the other.
The stress findings come from press coverage. According to Medical Xpress, which reported on the UC Santa Cruz work, mice given a chronic unpredictable mild stress protocol, a model of depression-like states, showed a larger burst of new connections after psilocybin. The coverage also says the drug halted the heavy loss of existing connections that stress normally causes. In unstressed mice, it reported, the extra connections faded toward baseline over about three weeks.
The coverage quotes senior author Yi Zuo saying the findings "challenge the prevailing view that psilocybin simply increases neural connectivity and suggest that its effects depend on the brain's underlying condition." That is the researchers' interpretation, and it rests on mouse data.
Several limits apply. Mice are not people. A stress model is not the same as years of human stress. Nothing here shows that psilocybin protects the aging brain or improves health in healthy adults. Psilocybin remains unapproved, and its use for aging is unproven.
What to watch next
Whether the stress results are confirmed in the full paper with animal numbers and effect sizes, and whether human studies show that these changes in connections track real clinical benefit.